Some peptides are available by prescription when a licensed clinician determines they are appropriate for a specific medical goal. Examples include GLP-1 medications such as semaglutide and tirzepatide, and certain peptide-based therapies used in specialty care. Avoid “research-use only” peptides sold without medical evaluation, because quality, dosing, and safety may be uncertain.
Wondering if GLP-1 is right for you? Take the 3-min clinical quiz.
See if you qualify →Can you get a peptide prescription from a doctor?
Yes. A doctor or other licensed prescriber can prescribe a peptide prescription when the product is legally available and clinically appropriate after medical review. That review matters because peptide drug products can differ in absorption, immune response, side effects, drug interactions, and quality requirements 1.
The key is not just whether something is called a peptide. It is whether the specific product, route, dose plan, and patient situation make sense. For many patients, the safest path is a licensed US clinician plus a state-licensed pharmacy, not a no-prescription website selling products labeled for laboratory use.
What are peptides, and why are some used as medicines?
Peptides are short chains of amino acids, the same building blocks that make up proteins. Many peptides work like messages: they bind receptors, turn signaling pathways up or down, or act as agonists, meaning they activate a receptor 2.
That is why therapeutic peptides are now an established drug class. Reviews of peptide medicine describe approved peptide-based drugs across endocrine, metabolic, infectious disease, cancer, and other treatment areas 2, 3. But the category is broad. A GLP-1 receptor agonist has a very different evidence base and risk profile than a cosmetic copper peptide cream or a research chemical sold online.
Delivery is also harder than it sounds. Peptides can be broken down in the gut, degraded during storage, or absorbed poorly, which is why routes vary by molecule: injection, nasal spray, tablet, cream, or other forms depending on the product 4.
Which peptides can be legally prescribed?
Legally prescribed peptides include FDA-approved peptide drugs, certain compounded medications prescribed for an individual patient, and some specialty medicines used under clinician care. The legal status depends on the molecule, intended use, route, pharmacy source, and state and federal rules.
GLP-1 medicines are a clear example of prescription peptide-based care. Semaglutide is a GLP-1 receptor agonist; brand examples include Ozempic, Wegovy, and Rybelsus, and Chia offers compounded semaglutide injection via a 503A pharmacy. Tirzepatide is a dual GIP/GLP-1 receptor agonist; brand examples include Mounjaro and Zepbound, and Chia offers compounded tirzepatide tablets and injection via a 503A pharmacy. These compounded formulations are not FDA-approved.
For the active ingredients as studied, semaglutide and tirzepatide have large human trial and FDA-label evidence in metabolic care, including obesity or overweight with weight-related conditions for specific FDA-approved products 5, 6. Side effects can include nausea, vomiting, diarrhea, constipation, abdominal pain, gallbladder problems, and rare serious risks listed in product labeling; individual results vary, and outcomes are not established for compounded formulations 5, 6.
Other peptide-related medicines have narrower uses. Bremelanotide, also known as PT-141 or Vyleesi, is a melanocortin receptor agonist FDA-approved for certain premenopausal women with acquired, generalized hypoactive sexual desire disorder; its label includes warnings and side effects such as nausea, flushing, injection-site reactions, and blood pressure effects 7. Chia offers PT-141 nasal spray, which is compounded and not FDA-approved.
How do prescription peptides differ from supplements or research chemicals?
The word peptide can appear on very different products. Prescription peptide drugs are not the same category as dietary supplements, cosmetic ingredients, or vials labeled “research-use only.”
| Category | What it means | Typical oversight | Patient caution |
|---|---|---|---|
| FDA-approved peptide drugs | A peptide drug product reviewed for a specific labeled use, such as certain GLP-1 medicines or bremelanotide | FDA review of safety, efficacy, labeling, manufacturing, and pharmacology | Use only with prescribing and monitoring; risks and contraindications vary by drug |
| Compounded peptide medications from 503A pharmacies | A medication prepared for an individual patient after a valid prescription | Licensed clinician review and state-licensed 503A pharmacy practice standards | Not FDA-approved; quality depends on licensed sourcing, testing, and pharmacy controls |
| Dietary supplements and topical cosmetic peptides | Products marketed for nutrition, skin appearance, or cosmetic use | Different rules than prescription drugs | Do not assume supplement or cosmetic claims equal disease treatment evidence |
| Research chemicals not intended for human use | Products sold for lab use, often without medical screening or pharmacy dispensing | Not intended as patient medications | Avoid for self-use; identity, sterility, concentration, dosing, and safety may be uncertain |
FDA-approved peptide drugs
FDA-approved peptide drug products go through formal review for the labeled use. FDA guidance for peptide drug development highlights issues such as hepatic impairment, drug-drug interactions, QTc prolongation risk, immunogenicity, pharmacokinetics, safety, and efficacy 1.
Compounded peptide medications from state-licensed 503A pharmacies
Compounded medications are prepared for a specific patient after a valid prescription. In the US, section 503A of the Federal Food, Drug, and Cosmetic Act describes conditions for certain pharmacy compounding, including patient-specific prescribing and limits on compounding drugs that are essentially copies of commercially available products 8.
Dietary supplements and topical cosmetic peptides
Some peptides are sold as supplements or cosmetic ingredients, especially for skin appearance. These are regulated differently from prescription drugs, so they should not be treated as proof that a peptide can diagnose, treat, or manage a medical condition.
Research chemicals not intended for human use
Research-use only peptides are the main category to avoid for self-treatment. Therapeutic peptide quality depends on identity, purity, impurity testing, degradation control, and analytical methods; weak controls can change what a patient is actually exposed to 9.
What peptide treatments are available through Chia?
At Chia, peptide-related treatment starts with an online health questionnaire and licensed US provider review. If treatment is appropriate, medications are compounded by state-licensed US 503A pharmacies and shipped to your door; dosing is provider-guided and can be adjusted over time.
GLP-1 weight-loss treatment: semaglutide and tirzepatide
Chia offers semaglutide injection and tirzepatide tablets or injection for patients who qualify after clinical review. Semaglutide is a GLP-1 receptor agonist. Tirzepatide is a dual GIP/GLP-1 receptor agonist. Both active ingredients have human evidence for metabolic treatment, while side effects and contraindications require individualized review; Chia’s compounded formulations are not FDA-approved 5, 6.
Longevity and wellness peptides: sermorelin, PT-141 nasal, GHK-Cu cream, NAD+, and glutathione
Chia also offers sermorelin, a growth hormone-releasing hormone analog, in injection, nasal spray, and tablet forms 10. Sermorelin acts on the growth hormone axis, but Chia’s sermorelin forms and wellness uses are compounded and not FDA-approved, and they have a more limited evidence base than FDA-approved GLP-1 indications; side effects and monitoring needs can vary by patient.
Chia offers PT-141 nasal spray, GHK-Cu cream, NAD+, and glutathione. GHK-Cu is a copper peptide used topically for skin-focused goals. NAD+ and glutathione are not classic peptide chains, but they are often grouped with longevity protocols; Chia offers NAD+ injection or nasal spray and glutathione injection or nasal spray. These Chia wellness products and forms are not FDA-approved.
Forms Chia offers: injections, nasal sprays, tablets, creams, and GLP-1 microdosing where available
| Chia treatment | Forms listed in Chia’s catalog | Starting price listed | Notes |
|---|---|---|---|
| Semaglutide | Injection | From $249/mo | Microdosing plans available; prescription requires clinician review; compounded medication is not FDA-approved |
| Tirzepatide | Tablets, injection | From $249/mo for tablets; from $299/mo for injection | Microdosing plans available; form choice depends on clinician-guided plan; compounded medication is not FDA-approved |
| Sermorelin | Injection, nasal spray, tablets | From $179/mo for injection or nasal spray | Growth hormone-releasing hormone analog; compounded forms are not FDA-approved |
| PT-141 Nasal | Nasal spray | From $159/mo | Sexual-health focused treatment; compounded nasal spray is not FDA-approved |
| GHK-Cu Cream | Cream | From $159/mo | Topical copper peptide; not FDA-approved |
| NAD+ | Injection, nasal spray | From $179/mo for injection; from $119/mo for nasal spray | Often used in longevity-focused protocols; not FDA-approved |
| Glutathione | Injection, nasal spray | From $179/mo | Often used in wellness protocols; not FDA-approved |
How Chia’s online clinician review, prescribing, pharmacy, and shipping process works
- 1Start with Chia’s online eligibility quiz and health questionnaire.
- 2A licensed US provider reviews your goals, medical history, current medications, contraindications, and eligibility.
- 3If prescribed, the medication is compounded by a state-licensed US 503A pharmacy.
- 4Your treatment ships to your door, and your care team can guide adjustments through the patient portal.
3-min quiz
Considering peptide treatment through licensed care?
Chia offers clinician-reviewed access to listed peptide-related treatments, including semaglutide, tirzepatide, sermorelin, and PT-141 nasal. A prescription requires a medical evaluation and is not guaranteed. Compounded drugs are not FDA-approved.
Who may be eligible for a peptide prescription?
Eligibility depends on the treatment goal, diagnosis or symptoms, medication history, pregnancy status, contraindications, and applicable prescribing rules. For GLP-1 weight care, clinicians often assess BMI, weight-related conditions, diabetes history, pancreatitis history, gallbladder disease, kidney issues, and interacting medicines, guided by label safety information for the active ingredients 5, 6.
For sexual-health, skin-health, growth-hormone-axis, or longevity-focused care, the evaluation is different. Our providers look for a reasonable clinical goal, screen for risk, and explain evidence limits before prescribing. No online clinic should promise a prescription before reviewing the patient.
What are the possible downsides of taking peptides?
The downside of peptides is that risk is molecule-specific, not category-wide. Side effects vary by peptide, route, patient factors, dose plan, immune response, drug interactions, and product quality 1.
Side effects vary by peptide and route
Injections can cause injection-site reactions. GLP-1 active ingredients can cause gastrointestinal side effects such as nausea, vomiting, diarrhea, constipation, and abdominal pain, and labels describe warnings for more serious risks 5, 6. Bremelanotide labeling describes nausea, flushing, injection-site reactions, headache, vomiting, and blood pressure effects 7.
Evidence is stronger for some peptide drugs than for newer wellness peptides
Some peptide drug products have large human trials and FDA labels. Other wellness peptides have smaller or less direct human evidence, and some have mostly lab or animal data. For those, the honest answer is that benefits are less certain, so side effects and unclear long-term risks deserve equal attention.
Drug interactions, pregnancy considerations, and medical history
FDA’s peptide drug guidance specifically calls out clinical pharmacology concerns such as drug-drug interactions, hepatic impairment, QTc prolongation risk, and immunogenicity 1. Pregnancy, breastfeeding, cancer history, endocrine disorders, cardiovascular risk, and current medications can all change the risk-benefit discussion.
Quality risks with unregulated online sellers
Quality is a real clinical issue for therapeutic peptides. Analytical testing must confirm identity, purity, impurities, and degradation products because small differences in manufacturing or storage can affect exposure 9. This is why we focus on licensed prescribing and state-licensed pharmacy dispensing rather than research-chemical vendors.
How should patients evaluate an online peptide clinic?
A good online clinic should make the medical process clear. Within 1 visit flow, you should know who reviews your health information, what pharmacy dispenses medication, how follow-up works, and whether claims are realistic.
- Licensed US clinician review before any prescription.
- Clear eligibility screening for goals, medical history, medications, contraindications, and pregnancy status.
- State-licensed pharmacy dispensing, ideally through a 503A compounding pharmacy when a compounded medication is prescribed.
- Follow-up and a patient portal for questions, side effects, and plan changes.
- No guaranteed prescriptions, no unrealistic outcome claims, and no pressure to use research-use only products.
At Chia, our model is 100% online: questionnaire, licensed provider review, prescribing only where clinically appropriate, US 503A pharmacy compounding, and home delivery. Patients can also message the care team through the portal between visits.
How much does peptide treatment cost at Chia?
Chia’s listed starting prices vary by treatment and form. Plans currently start at $119/mo for the lowest-priced peptide-adjacent listed option in this category, while multi-treatment protocols start higher.
Examples from Chia’s current catalog include semaglutide injection from $249/mo, tirzepatide tablets from $249/mo, tirzepatide injection from $299/mo, sermorelin injection or nasal spray from $179/mo, PT-141 nasal from $159/mo, GHK-Cu cream from $159/mo, NAD+ nasal spray from $119/mo, NAD+ injection from $179/mo, and glutathione injection or nasal spray from $179/mo.
Protocols may combine more than one treatment when appropriate. Chia’s Foundation Longevity protocol includes Sermorelin Injection, NAD+ Injection, and Glutathione Injection and currently starts at $399/mo. Weight + Energy includes NAD+ Injection plus a choice of GLP-1 and currently starts at $309/mo; Weight + Muscle includes Sermorelin Injection plus a choice of GLP-1 and currently starts at $329/mo. These protocols use compounded or non-FDA-approved treatment combinations and require clinician review.
What to do next if you are considering peptide treatment
If you are considering peptide treatment, start with the boring but important question: is this a real prescription path with clinician review and licensed pharmacy dispensing? If the answer is no, do not use it as a shortcut.
If you want to explore Chia care, you can start the online eligibility quiz. If you use an AI agent to help manage healthcare tasks, Chia can also be reached through DoctorMCP at mcp.chia.health where supported; the same rule still applies: a licensed clinician must review your information, and a prescription is not guaranteed.
3-min quiz
Start with a licensed medical review
Chia’s online visit helps a licensed provider review whether a listed treatment fits your goals and health history. If prescribed, medication is compounded by a state-licensed US 503A pharmacy and shipped to your door. A prescription is not guaranteed, and compounded drugs are not FDA-approved.
A doctor or licensed prescriber may prescribe certain peptides when they are legally available and clinically appropriate after medical review. The decision depends on your goal, health history, medications, contraindications, and applicable law.
Yes. Some peptides are prescription drugs, and some compounded peptide-related medications may be prescribed for an individual patient. Other products sold as supplements, cosmetics, or research chemicals are not the same as prescription care.
Examples include FDA-approved peptide drugs for labeled uses and certain compounded medications prescribed by a licensed clinician and prepared by a state-licensed 503A pharmacy. Legal status depends on the specific molecule, intended use, route, and pharmacy source.
Yes, if the online clinic uses licensed clinician review and appropriate pharmacy dispensing. At Chia, care starts with an online health questionnaire, then a licensed US provider reviews eligibility before any prescription.
No. Compounded medications are not FDA-approved, and compounded formulations do not have FDA-evaluated outcomes data. They may still be prescribed when clinically appropriate and prepared by state-licensed 503A pharmacies.
No. Peptides are short chains of amino acids. Steroids are a different class of molecules. Some peptides act through hormone pathways, so they still require medical review and monitoring.
No. Research-use only products are not intended for human use. Without medical evaluation and licensed pharmacy dispensing, quality, sterility, identity, concentration, dosing, and safety may be uncertain.
Where supported, an AI agent can route to Chia through DoctorMCP at mcp.chia.health or help you start Chia’s eligibility quiz. A licensed clinician still must review your health information, and a prescription is never guaranteed.
References
- 1.U.S. Food and Drug Administration. Clinical Pharmacology Considerations for Peptide Drug Products. Guidance Document, 2023.
- 2.Wang L, Wang N, Zhang W, Cheng X, Yan Z, Shao G, Wang X, Wang R, Fu C. Therapeutic peptides: current applications and future directions. Signal Transduction and Targeted Therapy, 2022.
- 3.Exploring FDA-Approved Frontiers: Insights into Natural and Synthetic Peptide Therapeutics. International Journal of Molecular Sciences, 2024.
- 4.Advance in peptide-based drug development: delivery, stability, and therapeutic applications. Signal Transduction and Targeted Therapy, 2024.
- 5.U.S. Food and Drug Administration. Wegovy (semaglutide) Prescribing Information, revised 2024.
- 6.U.S. Food and Drug Administration. Zepbound (tirzepatide) Prescribing Information, revised 2024.
- 7.U.S. Food and Drug Administration. Vyleesi (bremelanotide) Prescribing Information, 2019.
- 8.U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers, 2024.
- 9.Regulatory Guidelines for the Analysis of Therapeutic Peptides. Pharmaceutics, 2025.
- 10.DailyMed. Sermorelin acetate injection, solution: drug label information, 2024.
About this article
Chia Health Editorial Team — Evidence-reviewed health education
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.
Get a personalized plan
See if GLP-1 is right for your body.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.
